![Todd Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 563 929 $ in data 31/05/2026
Todd Carter is currently Chief Scientific Officer at Voyager Therapeutics, Inc. since 2022.
Formerly, Dr. Carter was Senior Director-Biology at BrainCells, Inc. Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Texas A&M University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/02/2026 | 145.718 ( 0,24% ) | 563 929 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2018 |
| Società | Posizione | Fine |
|---|---|---|
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
